Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (81-90 of 496) with videos related to

Pageof 50
Sort By:
Neuropharmacology|June 16, 2000
The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572A Gobert, A Dekeyne, M J Millan
Neuroscience Letters|September 16, 1991
The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptorsM J Millan, K Bervoets, M Mavridis
Biological Research|January 1, 1993
Identification of guanine nucleotide binding proteins from Trypanosoma cruziJ Bubis, E J Millan, R Martinez
Pain|June 1, 1980
A non-beta-endorphinergic adenohypophyseal mechanism is essential for an analgetic response to stressM J Millan, R Przewłocki, A Herz
Neuropharmacology|April 1, 1997
8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553M J Millan, S Girardon, K Bervoets
Revue Francaise De Transfusion Et Immuno-Hematologie|September 1, 1978
[Systematic screening of hemoglobinopathies in blood donors in Guadeloupe (French West Indies)]H Fabritius, J Millan, Y Le Corroller
Neuropharmacology|October 17, 1998
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivoM J Millan, A Dekeyne, A Gobert
European Journal of Pharmacology|March 5, 1997
The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in ratsM J Millan, H Gressier, M Brocco
Neuropharmacology|April 29, 1999
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysisA Dekeyne, S Girardon, M J Millan
Brain Research|June 14, 2002
The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological studyFrançoise Lejeune, Alain Gobert, Mark J Millan
Pageof 50

Showing results (81-90 of 496) with videos related to

Sort By:
Pageof 50
Neuropharmacology|June 16, 2000
The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572A Gobert, A Dekeyne, M J Millan
Neuroscience Letters|September 16, 1991
The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptorsM J Millan, K Bervoets, M Mavridis
Biological Research|January 1, 1993
Identification of guanine nucleotide binding proteins from Trypanosoma cruziJ Bubis, E J Millan, R Martinez
Pain|June 1, 1980
A non-beta-endorphinergic adenohypophyseal mechanism is essential for an analgetic response to stressM J Millan, R Przewłocki, A Herz
Neuropharmacology|April 1, 1997
8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553M J Millan, S Girardon, K Bervoets
Revue Francaise De Transfusion Et Immuno-Hematologie|September 1, 1978
[Systematic screening of hemoglobinopathies in blood donors in Guadeloupe (French West Indies)]H Fabritius, J Millan, Y Le Corroller
Neuropharmacology|October 17, 1998
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivoM J Millan, A Dekeyne, A Gobert
European Journal of Pharmacology|March 5, 1997
The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in ratsM J Millan, H Gressier, M Brocco
Neuropharmacology|April 29, 1999
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysisA Dekeyne, S Girardon, M J Millan
Brain Research|June 14, 2002
The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological studyFrançoise Lejeune, Alain Gobert, Mark J Millan
Pageof 50